Summary
Latest filing:
Alex Hammacher is Director of Barinthus Biotherapeutics plc. (BRNS). 1 SEC Form 4 filing on record, dated 9 September 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Alex Hammacher has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Alex Hammacher's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mozart Aggregator II LP - $579.20M of MDLN open-market activity in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M of MDLN open-market activity in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M of DVA open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M of PBLS open-market activity in the last 12 months
- Fairmount Funds Management LLC - $399.66M of SYRE open-market activity in the last 12 months
- Robert M. Williams Jr. - $371.84M of AVAH open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Alex Hammacher?
Alex Hammacher is a corporate insider, tracked as Director of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alex Hammacher submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Alex Hammacher's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Alex Hammacher and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
